Safeguard Scientifics, Inc. (SFE)

NYSE - NYSE Real Time Price. Currency in USD
12.92-0.12 (-0.92%)
At close: 4:02 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close13.04
Bid11.88 x 100
Ask19.41 x 3800
Day's Range12.87 - 13.05
52wk Range11.40 - 18.07
1y Target EstN/A
Market Cap261.3M
P/E Ratio (ttm)-112.35
Avg Vol (3m)40,107
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswireyesterday

    Propeller Health Completes $21.5 Million Financing to Transform Respiratory Disease through Digitally-Guided Therapy

    MADISON, Wis., Oct. 20, 2016 /PRNewswire/ -- Propeller Health, the leading digital solution for respiratory medicine, today announced the closing of its $21.5 million Series C financing. The funding round includes new investors 3M Ventures, S.R. One, Limited and Hikma Ventures, and existing investors Safeguard Scientifics and Social Capital. Proceeds will be used to expand Propeller's digitally-guided therapy platform and modernize the management of respiratory disease.

  • Accesswire15 days ago

    Safeguard Scientifics to Present at The MicroCap Conference on October 24-25 in Philadelphia

    ARLINGTON, VA / ACCESSWIRE / October 6, 2016 / Safeguard Scientifics (NYSE: SFE) will be presenting at this year's The MicroCap Conference on October 24-25 in Philadelphia at the Hotel Monaco, along with ...

  • PR Newswire15 days ago

    Trice Medical Receives FDA 510(K) Clearance for mi-eye 2

    KING OF PRUSSIA, Pa., Oct. 6, 2016 /PRNewswire/ -- Trice Medical announced today that it received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for mi-eye 2, a disposable needle with a fully integrated camera that enables physicians to use advanced diagnostic imaging to visualize joint injuries in their clinic. The mi-eye 2 is designed for use in diagnostic and operative arthroscopic and endoscopic procedures to provide illumination and visualization of an interior cavity of the body through either a natural or surgical opening. The mi-eye 2 also provides physicians the ability to inject or aspirate under direct visualization.